Harrow (HROW) Minority Interest (2019 - 2026)

Harrow's (HROW) quarterly Minority Interest came in at -$355000.0 in Q1 2026, little changed year-on-year from -$355000.0 in Q1 2025, and little changed quarter-over-quarter from -$355000.0 in Q4 2025.

Harrow (HROW) Minority Interest (2019 - 2026) Analysis & Trends

Harrow's Minority Interest history runs 8 years deep, the most recent figure standing at -$355000.0 for Q1 2026.

  • On a quarterly basis, Minority Interest changed 0.0% year-over-year to -$355000.0 in Q1 2026; TTM through Mar 2026 was -$355000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at -$355000.0, changed 0.0% from the prior year.
  • Minority Interest steadied at -$355000.0 in Q1 2026 per HROW's latest filing, from -$355000.0 in the prior quarter.
  • Across five years, Minority Interest topped out at -$355000.0 in Q1 2022 and bottomed at -$355000.0 in Q1 2022.
  • The 5-year median for Minority Interest is -$355000.0 (2022), against an average of -$355000.0.
  • Biggest YoY gain for Minority Interest was 0.0% in 2022; the steepest drop was 0.0% in 2022.
  • Year by year, Minority Interest stood at -$355000.0 in 2022, then changed by 0.0% to -$355000.0 in 2023, then changed by 0.0% to -$355000.0 in 2024, then changed by 0.0% to -$355000.0 in 2025, then changed by 0.0% to -$355000.0 in 2026.
  • Per Business Quant, the three latest HROW Minority Interest figures stand at -$355000.0 (Q1 2026), -$355000.0 (Q4 2025), and -$355000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Harrow 1.56 Bn 1.47 Bn 27.05 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -355,000.00
Dec 31, 2025 -355,000.00
Sep 30, 2025 -355,000.00
Jun 30, 2025 -355,000.00
Mar 31, 2025 -355,000.00
Dec 31, 2024 -355,000.00
Sep 30, 2024 -355,000.00
Jun 30, 2024 -355,000.00
Mar 31, 2024 -355,000.00
Dec 31, 2023 -355,000.00
Sep 30, 2023 -355,000.00
Jun 30, 2023 -355,000.00
Mar 31, 2023 -355,000.00
Dec 31, 2022 -355,000.00
Sep 30, 2022 -355,000.00
Jun 30, 2022 -355,000.00
Mar 31, 2022 -355,000.00
Dec 31, 2021 -355,000.00
Sep 30, 2021 -355,000.00
Jun 30, 2021 -355,000.00